Coagulase-negative staphylococci: Role as pathogens

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 223-236

  Huebner, Johannes ^a,b   Goldmann, Donald A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antibiotic therapy; Device related infections; Endocarditis; Endophthalmitis; Shunt infection

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL POLYSACCHARIDE; CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; METICILLIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TROVAFLOXACIN; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENDOPHTHALMITIS; HOSPITALIZATION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL ADHESION; CATHETERS, INDWELLING; CEREBROSPINAL FLUID SHUNTS; COAGULASE; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENDOCARDITIS, BACTERIAL; ENDOPHTHALMITIS; EQUIPMENT CONTAMINATION; HEART VALVE PROSTHESIS; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; POLYSACCHARIDES, BACTERIAL; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 0033016317     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.223     Document Type: Review

References (69)

1. 1. Kloos WE, Schleifer KH. 1975. Simplified scheme for routine identification of human Staphylococcus species. J. Clin. Microbiol. 1:82-87
2. 1a. Boyce JM. 1997. Epidemiology and prevention of nosocomial infections. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:309-29. New York: Churchill Livingston
3. 2. Baird-Parker AC. 1974. The basis for the present classification of staphylococci and micrococci. Ann. NY Acad. Sci. 236:7-14
4. 3. Kloos WE. 1980. Natural populations of the genus Staphylococcus. Annu. Rev. Microbiol. 34:559-92
5. 4. De Buyser ML, Morvan A, Auber S, et al. 1992. Evaluation of a ribosomal gene probe for the identification of species and subspecies within the genus Staphylococcus. J. Gen. Microbiol. 138:889-99
6. 5. Goering RV, Winters MA. 1992. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis. J. Clin. Microbiol. 30:577-80
7. 6. Kotilainen P, Huovinen P, Eerola E. 1991. Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J. Clin. Microbiol. 29:315-22
8. 7. Alvarado CJ, Stolz SM, Maki DG. 1991. Nosocomial infections from contaminated endoscopes: a flawed automated endoscope washer. An investigation using molecular epidemiology. Am. J. Med. 91:272S-280S
9. 8. Endl J, Seidl PH, Fiedler F, Schleifer KH. 1983. Chemical composition and structure of cell wall teichoic acids of staphylococci. Arch. Microbiol. 135:215-23
10. 9. Kloos WE, Bannermann TL. 1994. Update on the clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7:117-40
11. 10. Noble WC, Pitcher DG. 1978. Microbial ecology of the human skin. Adv. Microbiol. Ecol. 2:245-53
12. 11. Kloos WE. 1997. Taxonomy and systematics of staphylococci indigenous to humans. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:113-37. New York: Churchill Livingston
13. 12. Jarlov JO, Hojberg T, Busch-Sorensen C, et al. 1996. Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. J. Hosp. Infect. 32:217-227
14. 13. Goldmann DA, Leclair J, Macone A. 1978. Bacterial colonization of neonates admitted to an intensive care environment. J. Pediatr. 93:288-93
15. 14. Herchline TE, Ayers LW. 1991. Occurrence of Staphylococcus lugdunesis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol. 29:419-21
16. 15. Low DE, Schmidt BK, Kirpalani HM, et al. 1992. An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients. Pediatrics 89:696-700
17. 16. Lambe DW Jr, Ferguson KP, Keplinger JL, et al. 1990. Pathogenicity of Staphylococcus lugdunesis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can. J. Microbiol. 36:455-63
18. 17. Kloos WE, Orban BS, Walker DD. 1981. Plasmid composition of Staphylococcus species. Can. J. Microbiol. 27:271-78
19. 18. Forbes BA, Schaberg DR. 1983. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J. Bacteriol. 153:627-34
20. 19. Archer GL, Johnston JL. 1983. Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides. Antimicrob. Agents Chemother. 24:70-77
21. 20. Wilkinson BJ. 1997. Biology. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:1-38. New York: Churchill Livingston
22. 21. Veenstra GJ, Cremers FFM, van Dijk H, Fleer A. 1996. Ultrastructural organization and regulation of a biomaterial adhesion of Staphylococcus epidermidis. J. Bacteriol. 178:537-41
23. 22. Hussain M, Herrmann M, von Eiff C, et al. 1997. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect. Immun. 65:519-24
24. 23. Rupp ME, Archer G. 1992. Hemagglutination and adherence to plastic by Staphylococcus epidermidis. Infect. Immun. 60:4322-27
25. 24. Gatermann S, Meyer HGW, Wanner G. 1992. Staphylococcus saprophyticus hemagglutinin is a 160-kilodalton surface protein. Infect. Immun. 60:4127-32
26. 25. Gatermann S, Kreft B, Marre R, et al. 1992. Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect. Immun. 60:1055-60
27. 26. Gatermann S, John J, Marre R. 1989. Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infections of rats. Infect. Immun. 57:110-16
28. 27. Bayston R, Penny SR. 1972. Excessive production of mucoid substances in Staphylococcus SIIA: a possible factor in colonization of Holter shunts. Dev. Med. Child. Neurol. 14:25-8 (Suppl.)
29. 28. Christensen GD, Simpson WA, Younger JJ, et al. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006
30. 29. Peters G, Locci R, Pulverer G. 1982. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J. Infect. Dis. 146:479-82
31. 30. Tojo M, Yamashita N, Goldmann DA, Pier GB. 1988. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J. Infect. Dis. 157:713-22
32. 31. Kojima Y, Tojo M, Goldmann DA, et al. 1990. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J. Infect. Dis. 162:435-41
33. 32. Takeda S, Pier GB, Kojima Y, et al. 1991. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation 84:2539-46
34. 33. Fattom A, Shepherd S, Karakawa W. 1992. Capsular polysaccharides serotyping scheme for Staphylococcus epidermidis. J. Clin. Microbiol. 30:3270-73
35. 34. Baldassarri L, Donnelli G, Gelosia A, et al. 1996. Purification and characterization of the staphylococcal slime-associated antigen and its occurence among Staphylococcus epidermidis. Infect. Immun. 64:3410-15
36. 35. Mack D, Fischer W, Krokotsch A, et al. 1996. The intracellular adhesion involved in biofilm accumulation of Staphylococcus epidermidis is a linear ß-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178:175-83
37. 36. Heilmann C, Schweitzer O, Gerke C, et al. 1996. Molecular basis of intracellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20:1083-91
38. 37. Huebner J, Pier GB, Maslow JN, et al. 1994. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia strains in a neonatal ICU over a 10-year period. J. Infect. Dis. 169:526-31
39. 38. Arbeit RD. 1997. Laboratory procedures for epidemiological analysis. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:253-86. New York: Churchill Livingston
40. 39. Raad II, Bodey GP. 1992. Infectious complications of indwelling vascular catheters. Clin. Infect. Dis. 15:197-210
41. 40. Banerjee SN, Emori TG, Culver DH, et al. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am. J. Med. 91:86S-89S (Suppl. 3b)
42. 41. Archer GL. 1995. Staphylococcus epidermidis and other coagulase-negative Staphylococci. In Principles and Practice of Infectious Diseases, ed. GL Mandell, JE Bennett, R Dolin, 4:1777-84. New York: Churchill Livingston
43. 42. Malanoski GJ, Samore MH, Pefanis A, Krachmer AW. 1995. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch. Intern. Med. 155:1161-66
44. 43. CDC NNIS System. 1997. National Nosocomial Infections Surveillance (NNIS) Report, Data Summary from October 1986-April 1997, Issued May 1997. Am. J. Infect. Control 25:477-87
45. 44. Henderson DK. 1988. Intravascular device-associated infection: current concepts and controveries. Infect. Med. 5:459-64
46. 45. Roos KL, WM Scheld. 1997. Central nervous system infections. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:413-39. New York: Churchill Livingston
47. 46. Schoenbaum SC, Gardner P, Shillito J. 1975. Infection of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J. Infect. Dis. 131:543-52
48. 47. Frame PT, McLaurin RL. 1984. Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy. J. Neurosurg. 60:354-60
49. 48. Arber N, Militianu A, Ben-Yehuda A, et al. 1991. Native valve Staphylococcus epidermidis endocarditis: report of seven cases and review of the literature. Am. J. Med. 90:758-62
50. 49. Ing MB, Baddour LM, Bayer AS. 1997. Bacteremia and infective endocarditis: pathogenesis, diagnosis, and complications. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:331-54. New York: Churchill Livingston
51. 50. Wood CA, Sewell DL, Strausbaugh LJ. 1989. Vertebral osteomyelitis and native valve endocarditis caused by Staphylococcus warneri. Diagn. Microbiol. Infect. Dis. 12:261-63
52. 51. Shuttleworth R, Colby WD. 1992. Staphylococcus lugdunesis endocarditis. J. Clin. Microbiol. 30:1948-52
53. 52. Caputo GM, Archer GL, Calderwood SB, et al. 1987. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiological features. Am. J. Med. 83:619-25
54. 53. Karchmer AW, Archer GL, Dismukes WE. 1983. Staphylococcus epidermidis prosthetic valve endocarditis: microbiological and clinical observations as guide to therapy. Ann. Intern. Med. 98:447-55
55. 54. Gatermann SG, Crossley KB. 1997. Urinary tract infections. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:493-508. New York: Churchill Livingston
56. 55. Latham RH, Running K, Stamm WE. 1983. Urinary tract infections in young adult women caused by Staphylococcus saprophyticus. JAMA 250:3063-66
57. 56. Boyce JM, Potter-Bynoe G, Opal SM, et al. 1990. A common source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J. Infect. Dis. 161:493-99
58. 57. Duch-Samper AM, Menezo JL, Hurtado-Sarrio M. 1997. Endophthalmitis following penetrating eye injury. Acta Ophthalmol. Scand. 75:104-6
59. 58. Bannermann TL, Rhoden DL, McAllister SK, et al. 1997. The source of coagulase-negative staphylococci in the endophthalmitis vitrectomy study. A comparison of eyelid and intraocular isolates using pulsed-filed gel electrophoresis. Arch. Ophthalmol. 115:357-61
60. 59. Diamond JG. 1981. Intraocular management of endophthalmitis: a systematic approach. Arch. Ophthalmol. 99:96-99
61. 60. Smith MA, Sorensen JA, D'Aversa G, et al. 1997. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone. J. Infect. Dis. 175:462-66
62. 61. Ficker LA, Seal D. 1997. Disease of the eye. In The Staphylococci in Human Disease, ed. KB Crossley, GL Archer, 1:441-53. New York: Churchill Livingston
63. 62. Wilson WR, Karchmer AW, Dajani AS, et al. 1995. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 274:1706-13
64. 63. Eliopoulos GM. 1997. Vancomycin-resistant enterococci. Mechanism and clinical relevance. Infect. Dis. Clin. No. Am. 11:851-65
65. 64. Centers for Disease Control. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR Morb. Mortal. Wkly. Rep. 46:765-66
66. 65. Schwalbe RS, Stapelton JT, Gilligan PH. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Eng. J. Med. 316:927-31
67. 66. de Gorgolas M, Aviles P, Verdejo C, Guerrero MLF. 1995. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrob. Agents Chemother. 39:953-57
68. 67. Kaatz GW, Seo SM, Barriere SL, et al. 1989. Ciprofloxacin and rifampin, alone and in combination for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 33:1184-87
69. 68. Watanakunakorn C, Tisone JC. 1982. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 22:903-5